Search Results for: australia

MUSE cells are in 4 Japanese stem cell trials despite doubts

Professor-Mari-Dezawa-talking-about-MUSE-cells-on-national-TV-in-Japan.-Screenshot.

The stem cell universe is populated by sometimes mysterious acronyms (see an image of a whole alphabet stem cell acronym soup), many of which refer to specific kinds of stem cells including one nebulous type called MUSE cells. MUSE cells clinical trials I’m not convinced that MUSE cells exist, but oddly there appear to be […]

MUSE cells are in 4 Japanese stem cell trials despite doubts Read More »

My new Cell Stem Cell piece: too much carrot & not enough stick on stem cell oversight

carrot-and-sticks

I have a new Cell Stem Cell piece out today that aims to take stock of today’s stem cell regulatory oversight in the U.S., Japan, and elsewhere including Australia, Canada and India. I use a carrot and stick metaphor for encouraging legit research and taking regulatory action on serious non-compliant activities, respectively. Where is stem cell

My new Cell Stem Cell piece: too much carrot & not enough stick on stem cell oversight Read More »

List of regenerative medicine & stem cell meetings for rest of 2018

Stem-cell-meetings-2018

This post contains a list of the remaining regenerative medicine and stem cell meetings for 2018. If you are interested in history, here’s our first ever meetings list for way back in 2012. Here’s the 2018 list. 10th World Congress and Expo on Cell & Stem Cell Research, NY, NY USA, March 19-21, 2018. iPSCs: A

List of regenerative medicine & stem cell meetings for rest of 2018 Read More »

Mesoblast gets FDA RMAT; List of 10 total designations so far

Mesoblast-e1514313188176

Australian stem cell biotech Mesoblast announced that it has received regenerative medicine advanced therapy (RMAT) designation from the U.S. FDA. This is very good news for the company and an encouraging development for the field. Interestingly, last month the FDA clarified that there is expanded RMAT designation that can include gene therapies too. At the Meeting

Mesoblast gets FDA RMAT; List of 10 total designations so far Read More »

Doubts raised on key points of Nature paper on CRISPR gene editing of human embryos

Egli-Mitalipov-preprint

Is it possible that CRISPR gene editing actually didn’t happen in many of the human embryos in that big Nature paper that made such news a couple weeks back? Some doubts have emerged that call the main conclusions of the paper into question and argue that more definitive studies are needed to be sure. An

Doubts raised on key points of Nature paper on CRISPR gene editing of human embryos Read More »